EPCAM and lung cancer: In lung cancer, common targets such as MSLN, MUC1, PSCA, and epithelial cell adhesion molecule, have intratumoral heterogeneity, leading to an unsatisfactory outcome of CAT-T cell therapy in lung cancer (21).